These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 32030850)
1. Estrogen-related receptor-α promotes gallbladder cancer development by enhancing the transcription of Nectin-4. Wang L; Yang M; Guo X; Yang Z; Liu S; Ji Y; Jin H Cancer Sci; 2020 May; 111(5):1514-1527. PubMed ID: 32030850 [TBL] [Abstract][Full Text] [Related]
2. A novel PI3K/AKT signaling axis mediates Nectin-4-induced gallbladder cancer cell proliferation, metastasis and tumor growth. Zhang Y; Liu S; Wang L; Wu Y; Hao J; Wang Z; Lu W; Wang XA; Zhang F; Cao Y; Liang H; Li H; Ye Y; Ma Q; Zhao S; Shu Y; Bao R; Jiang L; Hu Y; Zhou J; Chen L; Liu Y Cancer Lett; 2016 May; 375(1):179-189. PubMed ID: 26949052 [TBL] [Abstract][Full Text] [Related]
3. PI3K/AKT phosphorylation activates ERRα by upregulating PGC‑1α and PGC‑1β in gallbladder cancer. Wang L; Yang M; Jin H Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34184087 [TBL] [Abstract][Full Text] [Related]
4. TROP2 promotes proliferation, migration and metastasis of gallbladder cancer cells by regulating PI3K/AKT pathway and inducing EMT. Li X; Teng S; Zhang Y; Zhang W; Zhang X; Xu K; Yao H; Yao J; Wang H; Liang X; Hu Z Oncotarget; 2017 Jul; 8(29):47052-47063. PubMed ID: 28423362 [TBL] [Abstract][Full Text] [Related]
5. TASP1 Promotes Gallbladder Cancer Cell Proliferation and Metastasis by Up-regulating FAM49B via PI3K/AKT Pathway. Zhang Y; Du P; Li Y; Zhu Q; Song X; Liu S; Hao J; Liu L; Liu F; Hu Y; Jiang L; Ma Q; Lu W; Liu Y Int J Biol Sci; 2020; 16(5):739-751. PubMed ID: 32071545 [TBL] [Abstract][Full Text] [Related]
6. Loss of NDRG2 promotes epithelial-mesenchymal transition of gallbladder carcinoma cells through MMP-19-mediated Slug expression. Lee DG; Lee SH; Kim JS; Park J; Cho YL; Kim KS; Jo DY; Song IC; Kim N; Yun HJ; Park YJ; Lee SJ; Lee HG; Bae KH; Lee SC; Shim S; Kim YM; Kwon YG; Kim JM; Lee HJ; Min JK J Hepatol; 2015 Dec; 63(6):1429-39. PubMed ID: 26292259 [TBL] [Abstract][Full Text] [Related]
7. CCL18 secreted from M2 macrophages promotes migration and invasion via the PI3K/Akt pathway in gallbladder cancer. Zhou Z; Peng Y; Wu X; Meng S; Yu W; Zhao J; Zhang H; Wang J; Li W Cell Oncol (Dordr); 2019 Feb; 42(1):81-92. PubMed ID: 30276551 [TBL] [Abstract][Full Text] [Related]
8. STYK1 promotes cancer cell proliferation and malignant transformation by activating PI3K-AKT pathway in gallbladder carcinoma. Hu YP; Wu ZB; Jiang L; Jin YP; Li HF; Zhang YJ; Ma Q; Ye YY; Wang Z; Liu YC; Chen HZ; Liu YB Int J Biochem Cell Biol; 2018 Apr; 97():16-27. PubMed ID: 29413947 [TBL] [Abstract][Full Text] [Related]
9. The enhanced expression of estrogen-related receptor α in human bladder cancer tissues and the effects of estrogen-related receptor α knockdown on bladder cancer cells. Ye X; Guo J; Zhang H; Meng Q; Ma Y; Lin R; Yi X; Lu H; Bai X; Cheng J J Cell Biochem; 2019 Aug; 120(8):13841-13852. PubMed ID: 30977157 [TBL] [Abstract][Full Text] [Related]
10. Topoisomerase II alpha promotes gallbladder cancer proliferation and metastasis through activating phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin signaling pathway. Lyu WJ; Shu YJ; Liu YB; Dong P Chin Med J (Engl); 2020 Oct; 133(19):2321-2329. PubMed ID: 32925281 [TBL] [Abstract][Full Text] [Related]
11. SPOCK1 as a potential cancer prognostic marker promotes the proliferation and metastasis of gallbladder cancer cells by activating the PI3K/AKT pathway. Shu YJ; Weng H; Ye YY; Hu YP; Bao RF; Cao Y; Wang XA; Zhang F; Xiang SS; Li HF; Wu XS; Li ML; Jiang L; Lu W; Han BS; Jie ZG; Liu YB Mol Cancer; 2015 Jan; 14(1):12. PubMed ID: 25623055 [TBL] [Abstract][Full Text] [Related]
12. PLZF inhibits proliferation and metastasis of gallbladder cancer by regulating IFIT2. Shen H; Zhan M; Zhang Y; Huang S; Xu S; Huang X; He M; Yao Y; Man M; Wang J Cell Death Dis; 2018 Jan; 9(2):71. PubMed ID: 29358655 [TBL] [Abstract][Full Text] [Related]
13. Downregulation of BRD4 inhibits gallbladder cancer proliferation and metastasis and induces apoptosis via PI3K/AKT pathway. Hao J; Yang Z; Wang L; Zhang Y; Shu Y; Jiang L; Hu Y; Lv W; Dong P; Liu Y Int J Oncol; 2017 Sep; 51(3):823-831. PubMed ID: 28766687 [TBL] [Abstract][Full Text] [Related]
14. Ring finger protein 125, as a potential highly aggressive and unfavorable prognostic biomarker, promotes the invasion and metastasis of human gallbladder cancers via activating the TGF- β1-SMAD3-ID1 signaling pathway. Liu ZY; Cao J; Zhang JT; Xu GL; Li XP; Wang FT; Ansari KH; Mohamed H; Fan YZ Oncotarget; 2017 Jul; 8(30):49897-49914. PubMed ID: 28611292 [TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA CRNDE promotes gallbladder carcinoma carcinogenesis and as a scaffold of DMBT1 and C-IAP1 complexes to activating PI3K-AKT pathway. Shen S; Liu H; Wang Y; Wang J; Ni X; Ai Z; Pan H; Liu H; Shao Y Oncotarget; 2016 Nov; 7(45):72833-72844. PubMed ID: 27637083 [TBL] [Abstract][Full Text] [Related]
16. The microRNA miR-33a suppresses IL-6-induced tumor progression by binding Twist in gallbladder cancer. Zhang M; Gong W; Zuo B; Chu B; Tang Z; Zhang Y; Yang Y; Zhou D; Weng M; Qin Y; Ma M; Jiang A; Ma F; Quan Z Oncotarget; 2016 Nov; 7(48):78640-78652. PubMed ID: 27769047 [TBL] [Abstract][Full Text] [Related]
17. Overexpression of LncRNA AFAP1-AS1 predicts poor prognosis and promotes cells proliferation and invasion in gallbladder cancer. Ma F; Wang SH; Cai Q; Zhang MD; Yang Y; Ding J Biomed Pharmacother; 2016 Dec; 84():1249-1255. PubMed ID: 27810781 [TBL] [Abstract][Full Text] [Related]
18. KIF11 promotes cell proliferation via ERBB2/PI3K/AKT signaling pathway in gallbladder cancer. Wei D; Rui B; Qingquan F; Chen C; Ping HY; Xiaoling S; Hao W; Jun G Int J Biol Sci; 2021; 17(2):514-526. PubMed ID: 33613109 [TBL] [Abstract][Full Text] [Related]
19. Circular RNA FOXP1 promotes tumor progression and Warburg effect in gallbladder cancer by regulating PKLR expression. Wang S; Zhang Y; Cai Q; Ma M; Jin LY; Weng M; Zhou D; Tang Z; Wang JD; Quan Z Mol Cancer; 2019 Oct; 18(1):145. PubMed ID: 31623628 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of ERRα suppresses epithelial mesenchymal transition of triple negative breast cancer cells by directly targeting fibronectin. Wu YM; Chen ZJ; Liu H; Wei WD; Lu LL; Yang XL; Liang WT; Liu T; Liu HL; Du J; Wang HS Oncotarget; 2015 Sep; 6(28):25588-601. PubMed ID: 26160845 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]